Search Results
Found 2 results
510(k) Data Aggregation
(449 days)
The HILZO Esophageal Stents are indicated for use in esophageal strictures caused by intrinsic malignant tumors.
The HILZO Esophageal Stents are partially covered and fully covered, self-expanding tubular prosthesis designed to maintain patency of esophageal strictures. The HILZO Esophageal stents are available loaded on two styles of delivery devices, Over the Wire (OTW) and Through the Scope (TTS). The OTW delivery devices are 14Fr and the TTS is 10.5Fr to enable delivery through the working channel of an endoscope. The stents are made of Nitinol wire and are designed to prevent stent migration due to peristaltic motion and tumor in-growth. The stents are available in a variety models, diameters and lengths.
The document provided is a 510(k) Premarket Notification from the FDA for a medical device: the Hilzo Esophageal Stents. This type of submission is for demonstrating "substantial equivalence" to a legally marketed predicate device, not for establishing novel safety and effectiveness through clinical trials or performance studies involving complex metrics like those for AI/ML devices (e.g., sensitivity, specificity, clinical workflow improvement).
Therefore, the vast majority of the requested information regarding acceptance criteria, study design, ground truth establishment, expert adjudication, MRMC studies, and training set details are not applicable to this particular document. This document focuses on demonstrating that the new device is as safe and effective as a previously cleared device, primarily through bench testing comparing physical and mechanical properties, and biocompatibility.
Here's what can be extracted and what cannot:
1. A table of acceptance criteria and the reported device performance
The document provides a comparative table where "acceptance criteria" are implicitly defined by similarity to the predicate device's performance, often with an explicit acceptance range (e.g., "fell within the +/- 5% difference acceptance criteria").
Feature | Acceptance Criteria (compared to Niti-S Esophageal K080782) | Reported HILZO Esophageal Stent Performance Range / Value | Reported Niti-S Esophageal Performance Range / Value |
---|---|---|---|
Regulatory Number | Same | 878.3610 | 878.3610 |
Product Code | Same | ESW | ESW |
Indication for Use | Same | For esophageal strictures caused by intrinsic and/or extrinsic malignant tumors | For esophageal strictures caused by intrinsic and/or extrinsic malignant tumors |
Principle of Operation | Similar/Same (TTS and OTW models for HILZO, OTW for predicate) | TTS and OTW models available | OTW |
Biocompatibility | Biocompatible per ISO 10993 | Biocompatible per ISO 10993 (found to be) | Biocompatible per ISO 10993 |
Single Use | Yes | Yes | Yes |
Sterility | Eto | Eto | Eto |
Stent material | Nitinol | Nitinol | Nitinol |
Covering material | Similar (biocompatibility and mechanical testing support equivalence) | Silicone/PTFE | Silicone |
Stent diameter (mm) | Similar (compression & expansion testing support differences) | 18-20 mm | 16-20 mm |
Stent total length (mm) | Similar (compression & expansion testing support differences; context of other cleared stents) | 60-150 mm | 60-120 mm |
Stent head | Similar flaring stent head design | Silicone covered and uncovered flaring stent head design with/without removal string (lasso) | Silicon covered and uncovered flaring stent head design with/without removal string (lasso) |
Delivery Diameter | Similar (deployment testing and tensile strength demonstrate performance) | OTW - 14 Fr, 16 Fr; TTS - 10.5 Fr | OTW - 16 Fr and 20 Fr |
MR Status | MR Conditional | MR Conditional | MR Conditional |
Expansion Force | All results fell within ±5% difference | Range: 0.442-0.537 kgf (Avg.) | Range: 0.439-0.543 kgf (Avg.) |
Compression Force | All results fell within ±5% difference | Range: 3.073-3.925 kgf (Avg.) | Range: 3.093-3.914 kgf (Avg.) |
2. Sample size used for the test set and the data provenance
The document mentions "extensive biocompatibility data" and various "Non-Clinical Performance Testing" types (shelf-life, expansion force, compression force, etc.). However, it does not specify sample sizes for these tests. The data provenance would be that of the manufacturer's internal testing. It's retrospective in the sense that the tests were completed before the submission. No country of origin for specific test data is provided, but the manufacturer is Thoracent, Inc. in Huntington, NY, USA.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
This is not applicable. For this type of device (a physical medical implant), "ground truth" is established through engineering and biological performance standards, not expert medical opinion on a data set. The device is evaluated on its physical and mechanical properties and biocompatibility.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
Not applicable. There is no expert adjudication process for bench testing results in the way there would be for image interpretation in an AI/ML study.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This is a physical medical device (stent), not an AI/ML diagnostic or assistive software. MRMC studies are used for evaluating the impact of AI on human reader performance for diagnostic tasks.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable. This is a physical medical device, not an algorithm.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
For this device, "ground truth" is established through:
- Engineering specifications and standards: For mechanical properties like expansion and compression force, dimensions, tensile strength, kink resistance.
- Biocompatibility standards (e.S. ISO 10993): For biological safety, ensuring the materials are not toxic or harmful to the body.
- Sterilization validation: Ensuring the device can be terminally sterilized.
- MR safety standards: To determine if the device is safe for patients undergoing MRI.
8. The sample size for the training set
Not applicable. This is a physical medical device, not an AI/ML model that requires a training set.
9. How the ground truth for the training set was established
Not applicable. As above, no training set for an AI/ML model exists for this device.
Ask a specific question about this device
(234 days)
The BONASTENT® Tracheal/Bronchial Stent System is indicated for the treatment of tracheobronchial strictures caused by malignant neoplasms.
The BONASTENT® Tracheal/Bronchial (BTB) is a self-expanding tubular prosthesis designed to maintain patency of tracheobronchial strictures caused by malignant tumors. The stent is made of Nitinol wire and is weaved using a hook & cross wire construction; a silicon membrane covers the stent and is designed to prevent stent migration. Stent sizes range in diameter from 10mm to 20mm and in length from 50mm to 80mm.
The BONASTENT® Tracheal/Bronchial is available on two types of delivery devices. The Y-Shape Handle Delivery Device is used for stents with an outer diameter of 10Fr and less. The I-Shape Handle Delivery Device which is used for stents with an outer diameter larger than 10F.
The provided text describes the 510(k) Summary for the BONASTENT® Tracheal/Bronchial device. This document focuses on demonstrating substantial equivalence to a predicate device rather than presenting a study with explicit acceptance criteria and device performance metrics in the typical sense of a clinical trial. However, it does outline performance characteristics compared to its predicate.
Here's an analysis based on the information provided, framed to address your request for acceptance criteria and supporting studies where possible, while noting limitations due to the nature of a 510(k) summary for a stent:
1. Table of Acceptance Criteria and Reported Device Performance
For this specific device (a tracheal/bronchial stent), the "acceptance criteria" are implicitly defined by demonstrating equivalence to a legally marketed predicate device (AERO Tracheobronchial Stent System). The performance data supplied are comparative benchmarks rather than direct acceptance criteria against a defined threshold.
Performance Metric | Acceptance Criteria (Implicit: Comparable to Predicate) | Reported Device Performance (BONASTENT® Tracheal/Bronchial) | Predicate Device Performance (AERO Tracheobronchial) |
---|---|---|---|
Intended Use | Treatment of tracheobronchial strictures caused by malignant neoplasms. | Treatment of tracheobronchial strictures caused by malignant neoplasms. | Treatment of tracheobronchial strictures caused by malignant neoplasms. |
Stent Material | Nitinol | Nitinol | Nitinol |
Covering Material | (Compared for differences) | Silicone | Polyurethane membrane |
Stent Diameter (mm) | 10, 12, 14, 16, 18, 20 | 10, 12, 14, 16, 18, 20 | 10, 12, 14, 16, 18, 20 |
Stent Length (mm) | 20-80 | 20-80 | 20-80 |
Delivery Diameter | (Compared for differences) | 8F - 12F | 16F and 22F |
Deployment Time | (Reference, as predicate unknown) | Non-aged stents average 16.97 sec; Aged stents 16.4 sec | Unknown |
Expansion Force (10x20 stent) | Comparable to 0.390 lbs. (AERO) | 0.367 lbs. | 0.390 lbs. |
Expansion Force (20x80 stent) | Comparable to 0.763 lbs. (AERO) | 0.748 lbs. | 0.763 lbs. |
Compression Force (10x20 stent) | Comparable to 0.519 lbs. (AERO) | 0.517 lbs. | 0.519 lbs. |
Compression Force (20x80 stent) | Comparable to 1.026 lbs. (AERO) | 1.026 lbs. | 1.026 lbs. |
Corrosion Resistance (in simulated gastric fluid) | Comparable to predicate (which is unknown, but "Resistant" is the claim) | Resistant to corrosion for a duration equivalent to 3 years | Unknown |
Biocompatibility | Demonstrated | Passed various tests (Cytotoxicity, Maximization sensitization, Acute systemic toxicity, Rabbit Pyrogen Study, Intracutaneous reactivity, Bacterial reverse mutation assay, Intramuscular implantation study) | Passed (implied previous results for reference devices) |
Deployment Testing | Accuracy and repeatability of the delivery system validated. | All components, subassemblies, and/or full devices met required specifications. | N/A (Internal test) |
Dimensional Testing | Reproducibility of stent length and diameter after deployment verified. | All components, subassemblies, and/or full devices met required specifications. | N/A (Internal test) |
Tensile Strength Tests | Performed for deployment system components with bonds/welds. | All components, subassemblies, and/or full devices met required specifications. | N/A (Internal test) |
2. Sample Size Used for the Test Set and Data Provenance
The "test set" in this context refers to the samples used in bench testing.
- Sample Size: Not explicitly stated for each test, but implied to be sufficient for the validation and comparative testing performed on the stent models (e.g., 10x20 and 20x80 stents) and deployment systems.
- Data Provenance: The studies are described as "Bench Testing" and "in-vitro tests," meaning they were conducted in a laboratory environment. There is no information regarding country of origin for the data or whether it's retrospective or prospective.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
Not applicable for this type of submission. This document pertains to bench testing and substantial equivalence, not a clinical study requiring expert ground truth for interpretation of medical data.
4. Adjudication Method for the Test Set
Not applicable. Adjudication methods like 2+1 or 3+1 refer to clinical data review, typically by medical experts for diagnoses or outcomes, which is not part of this bench testing summary.
5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This is a medical device (stent) submission, not an AI diagnostic or assistive device.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable. This is a medical device (stent) submission, not an algorithm.
7. The Type of Ground Truth Used
For the bench tests, the "ground truth" is defined by the physical properties measured against established engineering and material standards, or by direct comparison to the predicate device's measured performance. For instance, expansion force measurements are compared directly to the predicate's measurements. Biocompatibility relies on standardized tests.
8. The Sample Size for the Training Set
Not applicable. There is no "training set" as this is not a machine learning or AI device.
9. How the Ground Truth for the Training Set Was Established
Not applicable.
Ask a specific question about this device
Page 1 of 1